Sutro Biopharma, Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
STRO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
111 Oyster Point Blvd., South San Francisco, CA

Insiders trading volume in the past year

Sutro Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William J. Newell CEO, Director $1.4M Mar 5, 2025
Jane Chung Chief Executive Officer, Director $533K +$10K +1.92% Oct 15, 2025
Trevor Hallam Pres. Rsrch & Cf. Sctific Ofcr $508K Apr 14, 2023
Arturo Molina Chief Medical Officer $354K Mar 4, 2022
Shabbir Anik Chief Technical Ops. Officer $274K Mar 3, 2023
Venkatesh Srinivasan Chief Tech Op Officer $215K May 1, 2025
Hans-Peter Gerber Chief Scientific Officer $212K +$13.6K +6.85% Oct 15, 2025
Anne Borgman Chief Medical Officer $195K May 1, 2025
David Pauling Chief Admin. Ofcr. & GC $186K +$9.99K +5.69% Oct 15, 2025
Edward C. Albini Cfo And Secretary $142K May 15, 2025
Linda A. Fitzpatrick Chief People & Comm. Officer $135K May 1, 2025
Barbara Leyman Chief Business Officer $127K Jul 8, 2025
Nicki Vasquez Chief Port. Strat & Alnce Ofcr $71.3K Jan 29, 2024
Brunilda Shtylla Chief Business Officer $41.2K Aug 28, 2023
Connie Matsui Director $40K +$40K Oct 15, 2025
Gregory K. Chow Cfo $16K +$16K Oct 15, 2025
Jon Marc Wigginton Director Jun 6, 2025
Heidi Hunter Director Jun 6, 2025
John G. Freund Director Jun 6, 2024
James P. Panek Director Jun 6, 2025
Daniel H. Petree Director Jun 6, 2025
Michael Dybbs Director Jun 6, 2025
Sukhi Jagpal Director Jun 6, 2025
Joseph M. Lobacki Director Jun 6, 2025
Shalini Sharp Director Jun 6, 2022

Recent Insider Transactions by Companies or Individuals for Sutro Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.